248 related articles for article (PubMed ID: 25321615)
1. A novel bioreactor for mechanobiological studies of engineered heart valve tissue formation under pulmonary arterial physiological flow conditions.
Ramaswamy S; Boronyak SM; Le T; Holmes A; Sotiropoulos F; Sacks MS
J Biomech Eng; 2014 Dec; 136(12):121009. PubMed ID: 25321615
[TBL] [Abstract][Full Text] [Related]
2. Computational simulations predict a key role for oscillatory fluid shear stress in de novo valvular tissue formation.
Salinas M; Ramaswamy S
J Biomech; 2014 Nov; 47(14):3517-23. PubMed ID: 25262874
[TBL] [Abstract][Full Text] [Related]
3. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
Engelmayr GC; Sales VL; Mayer JE; Sacks MS
Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
[TBL] [Abstract][Full Text] [Related]
4. A novel flex-stretch-flow bioreactor for the study of engineered heart valve tissue mechanobiology.
Engelmayr GC; Soletti L; Vigmostad SC; Budilarto SG; Federspiel WJ; Chandran KB; Vorp DA; Sacks MS
Ann Biomed Eng; 2008 May; 36(5):700-12. PubMed ID: 18253834
[TBL] [Abstract][Full Text] [Related]
5. A "sweet-spot" for fluid-induced oscillations in the conditioning of stem cell-based engineered heart valve tissues.
Williams A; Nasim S; Salinas M; Moshkforoush A; Tsoukias N; Ramaswamy S
J Biomech; 2017 Dec; 65():40-48. PubMed ID: 29054608
[TBL] [Abstract][Full Text] [Related]
6. The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cells.
Ramaswamy S; Gottlieb D; Engelmayr GC; Aikawa E; Schmidt DE; Gaitan-Leon DM; Sales VL; Mayer JE; Sacks MS
Biomaterials; 2010 Feb; 31(6):1114-25. PubMed ID: 19944458
[TBL] [Abstract][Full Text] [Related]
7. Differentiation and Distribution of Marrow Stem Cells in Flex-Flow Environments Demonstrate Support of the Valvular Phenotype.
Rath S; Salinas M; Villegas AG; Ramaswamy S
PLoS One; 2015; 10(11):e0141802. PubMed ID: 26536240
[TBL] [Abstract][Full Text] [Related]
8. Relative Effects of Fluid Oscillations and Nutrient Transport in the In Vitro Growth of Valvular Tissues.
Salinas M; Rath S; Villegas A; Unnikrishnan V; Ramaswamy S
Cardiovasc Eng Technol; 2016 Jun; 7(2):170-81. PubMed ID: 26857014
[TBL] [Abstract][Full Text] [Related]
9. The independent role of cyclic flexure in the early in vitro development of an engineered heart valve tissue.
Engelmayr GC; Rabkin E; Sutherland FW; Schoen FJ; Mayer JE; Sacks MS
Biomaterials; 2005 Jan; 26(2):175-87. PubMed ID: 15207464
[TBL] [Abstract][Full Text] [Related]
10. Design and testing of a cyclic stretch and flexure bioreactor for evaluating engineered heart valve tissues based on poly(glycerol sebacate) scaffolds.
Masoumi N; Howell MC; Johnson KL; Niesslein MJ; Gerber G; Engelmayr GC
Proc Inst Mech Eng H; 2014 Jun; 228(6):576-586. PubMed ID: 24898445
[TBL] [Abstract][Full Text] [Related]
11. Oscillatory shear stress created by fluid pulsatility versus flexed specimen configurations.
Salinas M; Schmidt DE; Libera M; Lange RR; Ramaswamy S
Comput Methods Biomech Biomed Engin; 2014 May; 17(7):728-39. PubMed ID: 22920330
[TBL] [Abstract][Full Text] [Related]
12. A novel bioreactor for the dynamic flexural stimulation of tissue engineered heart valve biomaterials.
Engelmayr GC; Hildebrand DK; Sutherland FW; Mayer JE; Sacks MS
Biomaterials; 2003 Jun; 24(14):2523-32. PubMed ID: 12695079
[TBL] [Abstract][Full Text] [Related]
13. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
[TBL] [Abstract][Full Text] [Related]
14. Effects of flow shear stress and mass transport on the construction of a large-scale tissue-engineered bone in a perfusion bioreactor.
Li D; Tang T; Lu J; Dai K
Tissue Eng Part A; 2009 Oct; 15(10):2773-83. PubMed ID: 19226211
[TBL] [Abstract][Full Text] [Related]
15. Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves.
Perry TE; Kaushal S; Sutherland FW; Guleserian KJ; Bischoff J; Sacks M; Mayer JE
Ann Thorac Surg; 2003 Mar; 75(3):761-7; discussion 767. PubMed ID: 12645690
[TBL] [Abstract][Full Text] [Related]
16. Concentric cylinder bioreactor for production of tissue engineered cartilage: effect of seeding density and hydrodynamic loading on construct development.
Saini S; Wick TM
Biotechnol Prog; 2003; 19(2):510-21. PubMed ID: 12675595
[TBL] [Abstract][Full Text] [Related]
17. Design of an ex vivo culture system to investigate the effects of shear stress on cardiovascular tissue.
Sucosky P; Padala M; Elhammali A; Balachandran K; Jo H; Yoganathan AP
J Biomech Eng; 2008 Jun; 130(3):035001. PubMed ID: 18532871
[TBL] [Abstract][Full Text] [Related]
18. Non-physiologic Bioreactor Processing Conditions for Heart Valve Tissue Engineering.
VeDepo MC; Buse EE; Paul A; Converse GL; Hopkins RA
Cardiovasc Eng Technol; 2019 Dec; 10(4):628-637. PubMed ID: 31650518
[TBL] [Abstract][Full Text] [Related]
19. A new approach to heart valve tissue engineering: mimicking the heart ventricle with a ventricular assist device in a novel bioreactor.
Kaasi A; Cestari IA; Stolf NA; Leirner AA; Hassager O; Cestari IN
J Tissue Eng Regen Med; 2011 Apr; 5(4):292-300. PubMed ID: 20687125
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of shear stresses in collagen-glycosaminoglycan and calcium phosphate scaffolds in bone tissue-engineering bioreactors.
Jungreuthmayer C; Donahue SW; Jaasma MJ; Al-Munajjed AA; Zanghellini J; Kelly DJ; O'Brien FJ
Tissue Eng Part A; 2009 May; 15(5):1141-9. PubMed ID: 18831686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
